Structure of an influenza group 2-neutralizing antibody targeting the hemagglutinin stem supersite.


Journal

Structure (London, England : 1993)
ISSN: 1878-4186
Titre abrégé: Structure
Pays: United States
ID NLM: 101087697

Informations de publication

Date de publication:
07 07 2022
Historique:
received: 29 06 2021
revised: 18 01 2022
accepted: 04 04 2022
pubmed: 1 5 2022
medline: 14 7 2022
entrez: 30 4 2022
Statut: ppublish

Résumé

Several influenza antibodies with broad group 2 neutralization have recently been isolated. Here, we analyze the structure, class, and binding of one of these antibodies from an H7N9 vaccine trial, 315-19-1D12. The cryo-EM structure of 315-19-1D12 Fab in complex with the hemagglutinin (HA) trimer revealed the antibody to recognize the helix A region of the HA stem, at the supersite of vulnerability recognized by group 1-specific and by cross-group-neutralizing antibodies. 315-19-1D12 was derived from HV1-2 and KV2-28 genes and appeared to form a new antibody class. Bioinformatic analysis indicated its group 2 neutralization specificity to be a consequence of four key residue positions. We specifically tested the impact of the group 1-specific N33 glycan, which decreased but did not abolish group 2 binding of 315-19-1D12. Overall, this study highlights the recognition of a broad group 2-neutralizing antibody, revealing unexpected diversity in neutralization specificity for antibodies that recognize the HA stem supersite.

Identifiants

pubmed: 35489332
pii: S0969-2126(22)00130-7
doi: 10.1016/j.str.2022.04.003
pmc: PMC9271601
mid: NIHMS1801616
pii:
doi:

Substances chimiques

Antibodies, Neutralizing 0
Hemagglutinin Glycoproteins, Influenza Virus 0
Hemagglutinins 0
Influenza Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Intramural Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

993-1003.e6

Subventions

Organisme : NIGMS NIH HHS
ID : P41 GM103310
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA AI005022
Pays : United States

Informations de copyright

Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Références

J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Cold Spring Harb Perspect Med. 2021 Aug 2;11(8):
pubmed: 32205415
J Virol. 2011 Oct;85(20):10905-8
pubmed: 21849447
Nature. 1980 Sep 25;287(5780):301-6
pubmed: 7421990
Nature. 1988 Jun 2;333(6172):426-31
pubmed: 3374584
Science. 1998 Jan 16;279(5349):393-6
pubmed: 9430591
Microbiol Rev. 1992 Mar;56(1):152-79
pubmed: 1579108
Nat Protoc. 2017 Feb;12(2):401-416
pubmed: 28125104
Immunity. 2018 Jan 16;48(1):174-184.e9
pubmed: 29343437
Protein Sci. 2018 Jan;27(1):293-315
pubmed: 29067766
Expert Rev Vaccines. 2020 Jun;19(6):563-577
pubmed: 32510256
Trends Microbiol. 2017 Sep;25(9):713-728
pubmed: 28734617
J Struct Biol. 2010 Mar;169(3):389-98
pubmed: 20018246
Immunity. 2012 Sep 21;37(3):412-25
pubmed: 22999947
Nucleic Acids Res. 2015 Jan;43(Database issue):D413-22
pubmed: 25378316
Nucleic Acids Res. 2004 Jul 1;32(Web Server issue):W615-9
pubmed: 15215462
J Virol. 2014 Apr;88(8):4047-57
pubmed: 24501410
J Virol. 2014 Dec;88(23):13580-92
pubmed: 25210195
Nature. 1981 Jan 29;289(5796):366-73
pubmed: 7464906
Biochem J. 1981 Mar 1;193(3):953-62
pubmed: 7305969
Sci Rep. 2018 Mar 12;8(1):4374
pubmed: 29531320
Nature. 2009 Jun 18;459(7249):931-9
pubmed: 19525932
J Struct Biol. 2009 Apr;166(1):95-102
pubmed: 19263523
PLoS One. 2008;3(12):e3942
pubmed: 19079604
Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):14216-21
pubmed: 21825125
Nat Methods. 2017 Mar;14(3):290-296
pubmed: 28165473
Science. 2012 Sep 14;337(6100):1343-8
pubmed: 22878502
Cell. 2016 Jul 28;166(3):596-608
pubmed: 27453466
J Struct Biol. 2016 Jan;193(1):1-12
pubmed: 26592709
J Struct Biol. 2015 Nov;192(2):216-21
pubmed: 26278980
Science. 2009 Apr 10;324(5924):246-51
pubmed: 19251591
Sci Immunol. 2017 Jul 14;2(13):
pubmed: 28783708
PLoS One. 2013 May 22;8(5):e63906
pubmed: 23717507
Biochem Biophys Res Commun. 2014 Jul 18;450(1):42-8
pubmed: 24858683
J Exp Med. 2011 Jan 17;208(1):181-93
pubmed: 21220454
Nat Commun. 2021 Mar 19;12(1):1722
pubmed: 33741916
Nat Methods. 2015 Oct;12(10):943-6
pubmed: 26280328
Nature. 1980 Aug 21;286(5775):771-6
pubmed: 7402351
Immunity. 2019 Aug 20;51(2):398-410.e5
pubmed: 31350180
Science. 2011 Aug 12;333(6044):843-50
pubmed: 21737702
PLoS Pathog. 2014 Aug 28;10(8):e1004337
pubmed: 25166308
Cell Rep. 2020 Sep 1;32(9):108088
pubmed: 32877670
Nat Struct Mol Biol. 2009 Mar;16(3):265-73
pubmed: 19234466
Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W503-8
pubmed: 18503082
J Virol. 2012 Mar;86(6):2978-89
pubmed: 22238297
Cell. 2016 Jul 28;166(3):609-623
pubmed: 27453470
Cell. 1993 May 21;73(4):823-32
pubmed: 8500173
Virology. 2004 Aug 1;325(2):287-96
pubmed: 15246268
Nature. 1998 Nov 5;396(6706):92-6
pubmed: 9817207
J Virol. 2015 Oct 14;90(1):76-91
pubmed: 26468542
Protein Sci. 2021 Jan;30(1):70-82
pubmed: 32881101
J Mol Biol. 2007 Sep 21;372(3):774-97
pubmed: 17681537
J Virol. 2013 Nov;87(22):12471-80
pubmed: 24027321
J Immunol Methods. 2008 Jan 1;329(1-2):112-24
pubmed: 17996249
Science. 2011 Aug 12;333(6044):850-6
pubmed: 21798894
Proc Natl Acad Sci U S A. 2008 Apr 22;105(16):5986-91
pubmed: 18413603
J Virol. 2013 Jun;87(12):7149-54
pubmed: 23552413
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
pubmed: 15572765
Nucleic Acids Res. 2019 Jan 8;47(D1):D339-D343
pubmed: 30357391
J Clin Invest. 2010 May;120(5):1663-73
pubmed: 20389023
Curr Opin Virol. 2012 Apr;2(2):134-41
pubmed: 22482710
Nat Struct Biol. 1995 Feb;2(2):163-70
pubmed: 7538429
Nature. 2005 Sep 8;437(7056):209-14
pubmed: 16079797
Protein Sci. 2013 Jan;22(1):74-82
pubmed: 23139141
Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):445-50
pubmed: 24335589
Curr Opin Virol. 2017 Jun;24:60-69
pubmed: 28527859
Immunity. 2013 Aug 22;39(2):245-58
pubmed: 23911655
J Struct Biol. 2005 Jul;151(1):41-60
pubmed: 15890530
J Comput Chem. 2015 May 15;36(13):996-1007
pubmed: 25824339
J Virol. 2020 Feb 28;94(6):
pubmed: 31826999
Nat Methods. 2017 Apr;14(4):331-332
pubmed: 28250466
J Virol. 2013 Dec;87(23):12619-35
pubmed: 24049169
J Mol Biol. 2017 Aug 18;429(17):2694-2709
pubmed: 28648617
Cell Host Microbe. 2020 Sep 9;28(3):434-444.e4
pubmed: 32619441
EMBO J. 2002 Mar 1;21(5):865-75
pubmed: 11867515
J Synchrotron Radiat. 2004 Jan 1;11(Pt 1):53-5
pubmed: 14646133
Proc Natl Acad Sci U S A. 2015 Jul 28;112(30):9430-5
pubmed: 26170284
J Struct Biol. 2012 Dec;180(3):519-30
pubmed: 23000701

Auteurs

Crystal Sao-Fong Cheung (CS)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Jason Gorman (J)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Sarah F Andrews (SF)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Reda Rawi (R)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Mateo Reveiz (M)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Chen-Hsiang Shen (CH)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Yiran Wang (Y)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Darcy R Harris (DR)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Alexandra F Nazzari (AF)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Adam S Olia (AS)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Julie Raab (J)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

I-Ting Teng (IT)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Raffaello Verardi (R)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Shuishu Wang (S)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Yongping Yang (Y)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Gwo-Yu Chuang (GY)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Adrian B McDermott (AB)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Tongqing Zhou (T)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Peter D Kwong (PD)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: pdkwong@nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH